Skip to main content

Table 2 Recommended pharmacological therapies for the hypothetical patient vignette

From: Australian GP management of osteoarthritis following the release of the RACGP guideline for the non-surgical management of hip and knee osteoarthritis

Drug

Number and percentage of respondentsa (n = 200)

Number and percentage of respondentsa (n = 79)

Signif.

2006

2013

n

%

95 % CI

n

%

95 % CI

Paracetamol (including slow release option)

190

95

91–97

72

91

83–96

0.349

Oral NSAID (conventional or COX-2 selective)

160

80

74–85

66

84

74–91

0.610

Topical NSAID (conventional or COX-2 selective)

19

10

6–14

1

1

0–6

0.032

Tramadol

29

15

10–20

24

30

21–42

0.004

Opioids–paracetamol plus codeine

28

14

9–20

14

18

10–28

0.550

Opioids–codeine

65

33

26–39

5

6

2–14

<0.001

Opioids–oxycodone, morphine or buprenorphine

10

5

3–9

16

20

12–31

<0.001

Intra-articular injections

12

6

4–10

8

10

5–19

0.344

Glucosamine and/or chondroitin

78

39

33–46

10

13

6–22

<0.001

Fish or krill oil

11

6

3–9

10

13

7–22

0.074

  1. aRespondents may have more than one response